• Browse Industries
• Health Care

• FDLI SmartBrief
• News
• Press Releases
• SmartBlogs
• Topics
• FDA
• Generic drugs
• Medical devices
• Nutrition
• Stem Cells
• Vaccines
• Jobs
• View Job Listings
• Post a Job
• Job Listings FAQ's
• Most Clicked Stories
• FDLI News
• FDLI Reader Polls
• Archive
• RSS

• Find/Post Jobs

• Partner With Us

• Advertise

• About SmartBrief

• Reader Polls

Latest News

Raptor Pharmaceutical's genetic disorder drug meets midstage study goals

Chicago Tribune | 13 hours 49 minutes ago

NOVATO, Calif. (AP) ? Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)

Pfizer, Immunovaccine will collaborate on cattle vaccines; terms of partnership not disclosed

Chicago Tribune | 13 hours 49 minutes ago

NEW YORK (AP) ? Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.... (more)

Vaccines on horizon for AIDS, Alzheimer's, herpes

Yahoo! | 14 hours 11 minutes ago

MARIETTA, Pa. ? Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.... (more)

Spray can prevent premature ejaculation: study

Yahoo! | 14 hours 12 minutes ago

WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)

Raptor's genetic disorder drug meets study goals

Seattle Times, The | 14 hours 12 minutes ago

Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)

Next-generation flu vaccine plant to open in U.S.

Reuters | 14 hours 13 minutes ago

WASHINGTON, Nov 23 (Reuters) - Novartis (NOVN.VX) will officially open the first next-generation flu vaccine plant in the United States on Tuesday, but it will be years before it makes its first vaccine.... (more)

Seattle Genetics receives $12 million in expansion of partnership with Astellas -- South Florida Sun-Sentinel.com

Sun-Sentinel (Fort Lauderdale, Fla.) | 14 hours 15 minutes ago

BOTHELL, Wash. (AP) — Seattle Genetics Inc. said Monday it will receive $12 million as part of an expanded collaboration with Astellas unit Agensys Inc.... (more)

UPDATE 1-Cumberland says injection meets main goal in study

Reuters | 14 hours 15 minutes ago

Nov 23 (Reuters) - Cumberland Pharmaceuticals Inc (CPIX.O) said its pain and fever treatment Caldolor met the main goal of reducing fever in burn patients over the first 24 hours of treatment in a study.... (more)

Pfizer, Immunovaccine in animal vaccine deal

San Francisco Chronicle | 14 hours 15 minutes ago

You must be signed in to add a comment. Sign In | Register... (more)

Intercytex closes Cambridge operation as assets sold off

Business Weekly (U.K.) | 14 hours 25 minutes ago

Stem cell company, Intercytex has closed down its Cambridge base as it hives off its assets ahead of a winding up of the business.... (more)

Europe drug stocks rally; Cephalon slides on study

MarketWatch | 14 hours 27 minutes ago

Drug stocks advanced in early action Monday, boosted by a rally among major European drugmakers, while shares of Cephalon Inc. fell on news that a later-stage clinical study for its pediatric drug Cinquil came up short-handed.... (more)

Pfizer Announces R&D Facility Consolidation - Pharmaceutical Technology

PharmTech.com | 15 hours 5 minutes ago

Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities.... (more)

257 Stories  |   RSS Feed

Sign up for FDLI SmartBrief

Latest Blog Postsview more

Job Listingsview more

Companies in the news

© 1999-2009 SmartBrief, Inc. |  Terms of Use |  Send Feedback |  Frequently Asked Questions (FAQ) |  Privacy and Legal Information

About SmartBrief |  Advertise with SmartBrief |  Sign up for Newsletters |  Partner with SmartBrief